Related Experiment Video
Updated: Feb 3, 2026

Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test
Published on: November 13, 2016
Leptin and its receptor in glucose metabolism of T-cell lymphoma
Tian-Jie Han1,2, Hong-Zhi Xu1, Jun-Shan Li3
1Department of Hematology, Shandong Provincial Hospital, Shandong University, Jinan, Shandong 250021, P.R. China.
Abstract:
T-cell lymphoma (TCL) is a group of heterogeneous disorders with a poor response to conventional treatment. In order to identify novel therapeutic targets, the present study investigated the effect of leptin and its receptor on glucose metabolism in TCL. The expression of the leptin receptor (ObR), and glucose transporter (Glut)1 and 4 was detected in TCL and reactive lymphoid hyperplasia (RLH) tissues by immunohistochemical analysis. A higher level of ObR expression was observed in the TCL tissues than in the RLH tissues (58.3 vs. 22.2%; P=0.012), and ObR overexpression was associated with high expression of Glut1 (P=0.007). In vitro analysis using the human TCL MOLT-3 cell line demonstrated that leptin stimulated cell glucose uptake via promoting recruitment and expression of Glut1, effects which were abolished by ObR-specific small interfering RNA (siRNA). Additionally, MOLT-3 cell viability was also increased following leptin treatment. ObR-specific siRNA abolished these responses. In conclusion, these results suggested that leptin serves a critical role in TCL glucose uptake via the ObR.
Insights
Leptin and its receptor (ObR) play a key role in T-cell lymphoma (TCL) glucose metabolism. Leptin boosts glucose uptake and cell viability in TCL by promoting glucose transporter 1 (Glut1) expression via ObR.
Area of Science:
- Oncology
- Metabolic Research
- Immunology
Background:
- T-cell lymphoma (TCL) presents heterogeneous disorders with limited treatment efficacy.
- Identifying novel therapeutic targets is crucial for improving TCL patient outcomes.
- Leptin signaling's role in cancer metabolism warrants further investigation.
Purpose of the Study:
- To investigate the impact of leptin and its receptor (ObR) on glucose metabolism in T-cell lymphoma.
- To determine the association between ObR expression and glucose transporter (Glut) expression in TCL.
- To elucidate the mechanism by which leptin influences glucose uptake and cell viability in TCL.
Main Methods:
- Immunohistochemical analysis of ObR, Glut1, and Glut4 expression in TCL and reactive lymphoid hyperplasia (RLH) tissues.
- In vitro studies using the human TCL MOLT-3 cell line.
- Treatment with leptin and ObR-specific small interfering RNA (siRNA) to assess effects on glucose uptake and cell viability.
Main Results:
- Significantly higher ObR expression was observed in TCL tissues compared to RLH tissues (58.3% vs. 22.2%, P=0.012).
- ObR overexpression in TCL tissues correlated with high Glut1 expression (P=0.007).
- Leptin treatment increased glucose uptake and Glut1 expression/recruitment in MOLT-3 cells, an effect reversed by ObR-specific siRNA.
- Leptin enhanced MOLT-3 cell viability, an effect also abolished by ObR-specific siRNA.
Conclusions:
- Leptin signaling through its receptor (ObR) is implicated in regulating glucose uptake in T-cell lymphoma.
- Leptin promotes glucose uptake and cell viability in TCL, potentially via Glut1.
- ObR represents a potential therapeutic target for modulating glucose metabolism in TCL.
More Related Videos
Related Concept Videos
What is Metabolism?
Types of Receptors: Cell Surface Receptors
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Internal Receptors
Receptor-mediated Endocytosis

